藥物成份

共有 21216 個藥物成份

NUTMEG POWDERED

關聯藥證數量
1

NUX VOMICA

關聯藥證數量
1

NUX VOMICA TINCTURE

關聯藥證數量
1

NYLIDRIN (SULFONATED STYROLDIVINYLBENZENE COPOLYMER)

關聯藥證數量
1

Na+/K+ Calibrating Standard/Flush Solution：140.0 mmol/L NaCl, 4.00 mmol/L KCl, TRIS buffer, surfactant, preservativeNa+/K+ Slope Standard：110.0 mmol/L NaCl, 8.0 mmol/L KCl,TRIS buffer,surfactant, preservativeD-1a：NaCl, KCl, CaCl2,LiCl, HCl, preservativeD-1b：Active pepsinC：NaCl NH4FH.FNa+/K+ Urine Diluent：0.055 M NaCl, 0.0044 M KCl, TRIS buffer, surfactant, preservative100Na/120k Urine Standard：0.100 M Na+, 0.120 M K+, preservative

關聯藥證數量
1

Na, K, Cl

關聯藥證數量
1

Na2HPO4．12H2O

關聯藥證數量
1

Na: 140 ± 1mM/L\nK: 4.2 ± 0.1mM/L\nCl: 102 ± 1mM/L\n

關聯藥證數量
1

NaCl

關聯藥證數量
1

NaCl 4.2 g KH2PO4 1 g K2PO4 3.1g Phenol Red 0.03 g Glycerol 300 mL

關聯藥證數量
1

NaCl (<0.5%), Na2SO4 (<1.0%) and preservatives (<0.01%) in an inorganic buffer compound (<0.8%).

關聯藥證數量
1

NaCl……………………………6.38 g/LH3BO3……………..…………….1.0 g/LNa2B4O7.10H2O…………………0.2 g/LC10H14N2K2O8.2H2O……………..0.2 g/L

關聯藥證數量
1

NaH2PO4．H2O

關聯藥證數量
1

NaOC1, pH 6.8 ± 0.2

關聯藥證數量
1

NaOH 2x 100 ml: sodium hydroxide 160 mmol/l\nPIC: 1 x 50 ml: picric acid 13.9 mmol/l\nSTD 1 x 25 ml: standard creatinine 2 mg/dl or 176.8 μmol/l\n

關聯藥證數量
1

NaOH, Organic acid, Salicylate, and NaOCl

關聯藥證數量
1

Nabumetone Content: 97.0 per cent to 102.0 per cent (anhydrous subtance)

關聯藥證數量
1

Naftifine HCl Assay calculated on dried basis (%, W/W): 99.0%~101.0%

關聯藥證數量
1

Naftopidil contains not less than 99.0%~101.0% of C24H28N2O3，calculated on the dried basis.

關聯藥證數量
1

Nalbuphine Hydrochloride contains 98%~102% (calculated as anhydrous basis)

關聯藥證數量
1

Nalbuphine Hydrochloride contains not less than 98.0% and not more than 102.0% of C21H27NO4．HCL, calculated on the dried basis.

關聯藥證數量
1

Naldemedine tosylate

關聯藥證數量
1

Nalidixic acid contains not less than 99.0% and not more than 101.0% of C12H12N2O3，calculated on the dried basis.

關聯藥證數量
1

Nalidixic acid contains not less than 99.0% and not more than the equivalent of 101.0% of 1-ethyl-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid, calculated with reference to the dried substance.

關聯藥證數量
1

Naloxone Hydrochloride (Dihydrate) contains 98.0 % to 102 % (anhydrous substance).

關聯藥證數量
1

Naltrexone Hydrochloride contains not less than 98.0% and not more than 102.0% of Naltrexone Hydrochloride , calculated on solvent free basis.

關聯藥證數量
1

Name：Taurine C2H7NO3S：125.15 2-Aminoethanesulfonic acid When dried, contains not less than 99.0% and not more than 101.0% of C2H7NO3S.

關聯藥證數量
1

Nanopia P-FDPBuffer Solution&#9312;: Tris(hydroxymeyhyl)aminomethane(pH8.5) 30mmol/LLatex Solution&#9313;: Antihuman FDP mouse monoclonal antibody-coated latex 2.5mg/mLFDP Control(#337123): 1mL x 2 conc. X 3FDP Calibrator(#315190): 0.5mL x 5 conc.

關聯藥證數量
1

Naphazoline Hydrochloride contains not less than 98.0 % and not more than 102.0 % of C14H15ClN2, calculated on the dried substance.

關聯藥證數量
1

Naphazoline Hydrochloride contains not less than 98.0% and not more than 102.0% of C14H14N2‧HCl, calculated on the dried basis.

關聯藥證數量
1

Naphazoline nitrate contains not less than 99.0% and not more than 101.0% of C14H15N3O3 calculated on the dried basis.

關聯藥證數量
1

Naproxen Sodium contains not less than 98.0% and not more than 102.0% of C14H13NaO3, calculated on the dried basis.

關聯藥證數量
1

Naproxen contains 98.5% to 101.5% of C14H14O3 calculated on the dried basis.

關聯藥證數量
1

Naproxen contains not less than 98.5 percent and not more than 101.5 percent of C14H14O3 calculated on the dried basis.

關聯藥證數量
1

Naproxen contains not less than 98.5% and not more than 101.5% of C14H14O3, calculated on the dried basis.

關聯藥證數量
1

Naproxen contains not less than 98.5% and not more than 101.5% of C14H14O3,calculated on the dried basis.

關聯藥證數量
1

Naproxen contains not less than 98.5% and not more than the equivalent of 100.5% of C14H14O3, calculated with reference to the dried substance.

關聯藥證數量
1

Naproxen contains not less than 99.0% and not more than 101.0% of C14H14O3, calculated on the dried substance.

關聯藥證數量
1

Natalizumab

關聯藥證數量
1

Native Black cohosh dry extract

關聯藥證數量
1

Native collagen fibrils (type I) from equine tendons suspended in isotonic glucose solution of pH 2.7.

關聯藥證數量
1

Natrium Heparin

關聯藥證數量
1

Natto Bacteria Powder

關聯藥證數量
1

Necitumumab

關聯藥證數量
1

Negative Control (1x2 mL): A 2-4% suspension of group O D-negative red blood cells.

關聯藥證數量
1

Negative Control (2.5ml). Lyophilized normal human serum containing a preservative. Each donor unit used in the preparation of this reagent has been found to be nonreactive for Hepatitis B surface antigen, anti-Hepatitis C and HIV-I/ II antibodies by FDA approved test procedures.

關聯藥證數量
1

Negative Control─0.1% sodium azide.

關聯藥證數量
1

Negative control latex：Sodium azide < 0.1%\nAnti-Staphylococcus aureus latex：Latex sensitized with human fibrinogen and anti-Staphylococcus aureus monoclonal antibodies.\nSodium azide <0.1%

關聯藥證數量
1

Negative control serum :\nHuman serum negative for anti-mannan Ab and tested negative for anti-HIV1 and anti-HIV2 antibodies, HBs antigen and anti-HCV antibody.\nPreservative: < 0.1% sodium azide.

關聯藥證數量
1

Neomycin Sulfate (USP) contains not less than 600 ug/mg of C23H46N6O13‧H2SO4, calculated on the dried basis.

關聯藥證數量
1

Neomycin Sulfate Content: minimum of 680 IU/mg (dried substance)

關聯藥證數量
1

Neomycin Sulfate has a potency equivalent to not less than 600 µg of neomycin per mg, calculated on the dried basis.

關聯藥證數量
1

Neomycin Sulfate it has a potency eqivalent to not less than 600 ug of neomycin per mg, calculated on the dried basis.

關聯藥證數量
1

Neomycin Sulfate it has potency equivalent to not less than 600 ug of neomycin per mg, calculated on the dried basis.

關聯藥證數量
1

Neostigmine Methylsulfate contains not less than 98.0% and not more than 102.0% of C13H22N2O6S, calculated on dried basis.

關聯藥證數量
1

Neostigmine Methylsulfate(=Neostigmine metilsulfate) contains not less than 98.5% and not more than 101.0% of C13H22N2O6S, calculated on the dried substance.

關聯藥證數量
1

Neostigmine Metilsulfate contains not less than 98.5% w/w and not more than 101.0% w/w of C13H22N2O6S, calculated on dried substance.

關聯藥證數量
1

Neratinib Maleate

關聯藥證數量
1

Netupitant

關聯藥證數量
1

Nevirapine Anhydrous contains not less than 98.0% and not more than 101.0% of C15H14N4O, calculated on the anhydrous basis.

關聯藥證數量
1

New born calf serm. 1vail

關聯藥證數量
1

Niacin Contents 98.0 to 102.0% w/w of C6H5NO2 (On Dried Basis)

關聯藥證數量
1

Niacin contains not less than 99.0% and not more than 101.0% of C6H5NO2, calculated on the dried basis.

關聯藥證數量
1

Niacinamide Free Flowing with 0.5% silicon dioxide

關聯藥證數量
1

Niacinamide contains not less than 99.0% and not more than 101.0% of C6H6N2O, calculated with reference to the dried substance.

關聯藥證數量
1

Nicardipine Hydrochloride contains NLT 98.0% and NMT 101.0% of nicardipine hydrochloride (C26H29N3O6‧HCl), calculated on the dried basis.

關聯藥證數量
1

Nicergoline contains not less than 99.0% and not more than 101.0% of C24H26BrN3O3, calculated on anhydrous substance.

關聯藥證數量
1

Nicergoline contains not less than 99.0% and not more than 101.0% of C24H26BrN3O3,calculated on the anhydrous and solvent-free substance.

關聯藥證數量
1

Nicorandil contains not less than 98.0% and not more than 102.0% of C8H9N3O4 calculated on anhydrous basis.

關聯藥證數量
1

Nicorandil contains not less than 98.5% and not more than 101.0% of C8H9N3O4, calculated on the anhydrous basis.

關聯藥證數量
1

Nicotinamide contains 99.0%~101.0% of C6H6N2O, calculated on the dried basis.

關聯藥證數量
1

Nicotinamide contains not less than 98.5% and not more than 101.5% of C6H6N2O, calculated on the dried basis.

關聯藥證數量
1

Nicotinamide contains not less than 99.0% and not more than the equivalent of 101.0% of pyridine-3-carboxamide, calculated with reference to the dried substance.

關聯藥證數量
1

Nicotinamide is pyridine-3-carboxamide.It contains not less than 99.0% and not more than 101.0% of C6H6N2O, calculated with reference to the dried substance.

關聯藥證數量
1

Nifedipine contains not less than 98.0% and not more than 102.0% of C17H18N2O6, calculated on the anhydrous basis.

關聯藥證數量
1

Nifedipine contains not less than 98.0% and not more than 102.0% of C17H18N2O6, calculated on the dried basis.

關聯藥證數量
1

Nifedipine contains not less than 98.0% and not more than 102.0% of C17H18N2O6, calculated on the dried substance.

關聯藥證數量
1

Nifuroxazide contains 98.5% to 101.5% of C12H9N3O5 (dried substance).

關聯藥證數量
1

Nimesulide contains 98.5% ~ 101.5% of C13H12N2O5S, calculated on the dried basis.

關聯藥證數量
1

Nimesulide contains not less than 98.5% and not more than 101.5% of C13H12N2O5S, calculated on the dried substances.

關聯藥證數量
1

Nimetazepam contains not less than 98.0% w/w to 102.0% w/w of C16H13N3O3, calculated on anhydrous substance.

關聯藥證數量
1

Nimodipine contains not less than 98.5% and not more than 101.5% of C21H26N2O7, calculated on the dried substance.

關聯藥證數量
1

Nintedanib Esylate contains 98.0%~102.0% (as anhydrous basis)

關聯藥證數量
1

Nintedanib Esylate contains Not Less Than 98.0% w/w and Not More Than 102.0% w/w of C31H33N5O4‧C2H6O3S, calculated on the anhydrous basis and solvent free basis.

關聯藥證數量
1

Nintedanib contains 98.0%~102.0% of C31H33N5O4 (as anhydrous basis)

關聯藥證數量
1

Nitrazepam contains not less than 99.0 % and not more than the equivalent of 101.0 % of C15H11N3O3, calculated with reference to the dried substance.

關聯藥證數量
1

Nitrazepam contains not less than 99.0% and not more than the equivalent of 101.0% of C15H11N3O3, calculated with reference to the dried substance.

關聯藥證數量
1

Nitric acid 10 mmol/L;\nCalcium carbonate 249.7 mg/L

關聯藥證數量
1

Nitrite-Detect Reagent: Contains 2 x 500 mL of N-1-naphthylethylenediamine and sulfanilamide in an acidic solution.\nNitrite-Detect 200μg/mL Control: Contains 1 x 25 mL of 200 μg/mL nitrite in an aqueous solution.\nNitrite-Detect Calibrator Kit: Contains 1 x 25 mL of negative nitrite calibrator and 1 x 25 mL of 500μg/mL nitrite in an aqueous solution.\nNitrite-Detect Control Kit: Contains 1 x 25 mL of Negative Control (375μg/mL nitrite) and 1 x 25 mL of Positive Control (625μg/mL nitrite) in an aqueous solution.\n

關聯藥證數量
1

Nitrocellulose Strip......………………………18 or 36 stripsNon-Reactive Control.....………………………..1 vial, 80μl.Strong Reactive Control...……………………..1 vial, 80μlWeak Reactive Control.....……………………….1 vial, 80μlStock Buffer Reactive Concentrate (10x)……...1 bottle, 20mlWash Buffer Reactive Concentrate (20x)...……1 bottle, 70mlConjugate........…………………………………..1 vial, 160μlSubstrate…………………………………...........1 vial, 100mlBlotting Powder......………………………………..10g/packet

關聯藥證數量
1

Nitrocellulose strips：18 or 36 strips\nNon-reactive control：1 vial (80ul)\nStrong reactive control：1 vial (80ul)\nWeak reactive control：1 vial (80ul)\nStock buffer concentrate (10x)：1 bottle (20 ml)\nWash buffer concentrate (20x)：1 bottle (70 ml)\nConjugate：1 vial (120ul)\nSubstrate： 1 bottle (100ml)\nBoltting powder：10 packets (1g each)\nIncubation trays：9 wells each 2 or 4 trays\nInstruction manual：1 copy\nForceps：1 pair\n

關聯藥證數量
1

Nitrofurantoin

關聯藥證數量
1

Nitrofurantoin contains not less than 98.0% and not more than 102.0% of C8H6N4O5，calculated on the anhydrous basis.

關聯藥證數量
1

Nitrofurazone dried at 105oC for 1 hour,contains not less than 98.0% and not more than 102.0% of C6H6N4O4

關聯藥證數量
1

Nitroso-PSAP 1.19 mmol/L

關聯藥證數量
1

Nitrous Oxide contains not less than 99.0% (v/v)

關聯藥證數量
1

Nizatidine contains not less than 98.0% and not more than 101.0% of C12H21N5O2S2, calculated on the dried basis.

關聯藥證數量
1

Nomegestrol acetate

關聯藥證數量
1

Nominal Values Used for the Manufactur of VITROS Chemistry Products Calibraotr Kit 9Analyte CalibratorVial 1 CalibraorVial 2 CalibraotorVial 3 units Calibraotorvial 1 Calibraotorvial2 Calibraotorvial unitsAcetaminophen (ACET) 10 95 335 μg/mL 66 629 2216 μmol/mLCarbamazepine (CRBM) 2.3 10.5 21.0 μg/mL 9.7 44.4 88.8 μmol/mLDigoxin (DGXN) 0.3 2.2 4.4 ng/mL 0.4 2.8 5.6 nmol/mLPhenobarbital (PHBR) 3.2 32.0 80.0 μg/mL 13.8 137.9 344.8 μmol/mLPhenytoin (PHYT) 2.2 15.0 40.0 μg/mL 8.7 59.4 158.4 μmol/mL

關聯藥證數量
1

Nominal Values Used for the Manufacture of VITROS Chemistry Products Calibrator Kit 2Analyte Calibrator Calibrator Calibrator Calibrator Units Vial 1* Vial 2* Vial 3* Vial 4* Carbonate 9 37 - 22 mmol/LChloride 65 - 150 - mmol/LCholesterol ** 180 450 - Mg/dLHDLCholesterol 47 180 - 5 mg/dLPotassium 2.0 120.0 11.0 25.0 mmol/LSodium 95 54 220 16 mmol/LTriglyceride 35 500 210 - mg/dL

關聯藥證數量
1